Quest Diagnostics
DGX
#1090
Rank
ยฃ13.59 B
Marketcap
ยฃ121.80
Share price
1.04%
Change (1 day)
13.58%
Change (1 year)
Quest Diagnostics is an American clinical laboratory company offering access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders and employment and court ordered drug testing.

Earnings for Quest Diagnostics (DGX)

Earnings in 2024 (TTM): ยฃ0.86 Billion

According to Quest Diagnostics 's latest financial reports the company's current earnings are ยฃ9.53 Billion. In 2023 the company made an earning of ยฃ0.89 Billion a decrease over its 2022 earnings that were of ยฃ0.98 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Quest Diagnostics from 1997 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) ยฃ0.86 B-3.67%
2023 ยฃ0.89 B-8.5%
2022 ยฃ0.98 B-52.48%
2021 ยฃ2.06 B37.95%
2020 ยฃ1.49 B75.09%
2019 ยฃ0.85 B16.2%
2018 ยฃ0.73 B-10.1%
2017 ยฃ0.81 B-5.16%
2016 ยฃ0.86 B-1.54%
2015 ยฃ0.87 B31%
2014 ยฃ0.66 B-37.52%
2013 ยฃ1.07 B26.93%
2012 ยฃ0.84 B24.01%
2011 ยฃ0.68 B-27.7%
2010 ยฃ0.94 B-3.55%
2009 ยฃ0.97 B19.59%
2008 ยฃ0.81 B12.54%
2007 ยฃ0.72 B-11.7%
2006 ยฃ0.82 B13.49%
2005 ยฃ0.72 B9.02%
2004 ยฃ0.66 B13.19%
2003 ยฃ0.58 B36.03%
2002 ยฃ0.43 B63.07%
2001 ยฃ0.26 B65.49%
2000 ยฃ0.15 B1297.84%
1999 ยฃ11.43 M-73.37%
1998 ยฃ42.96 M-384.21%
1997 -ยฃ15.12 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ยฃ0.65 B-26.12%๐Ÿ‡บ๐Ÿ‡ธ USA
-ยฃ2.35 Million-100.27%๐Ÿ‡บ๐Ÿ‡ธ USA
-ยฃ56.07 Million-106.33%๐Ÿ‡บ๐Ÿ‡ธ USA
-ยฃ7.82 Million-100.88%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ33.16 M-96.26%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.12 B-85.69%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands